Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders
- Wednesday, August 10, 2022, 7:30
- PR Newswire
- Add a comment
PSIL-001 and PSIL-002 show promising antidepressant effects without hallucinations while having improved learning and memory tendencies over a psilocybin mimic TAMPA, Fla., Aug. 10, 2022 /PRNewswire/ — Psilera Inc. (“Psilera”), a biopharmaceutical company optimizing next-generation…
About the Author
admin has written 21876 stories on this site.